We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.12B
AUM Growth
-$453M
Cap. Flow
-$364M
Cap. Flow %
-17.13%
Top 10 Hldgs %
34.33%
Holding
91
New
7
Increased
22
Reduced
20
Closed
19

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$27.3M
2
VEEV icon
Veeva Systems
VEEV
+$16.4M
3
IMGN
Immunogen Inc
IMGN
+$14.5M
4
DAWN
Day One Biopharmaceuticals
DAWN
+$14.1M
5
TSBX
Turnstone Biologics
TSBX
+$13.6M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$112M
2
PEN icon
Penumbra
PEN
+$46.5M
3
SYK icon
Stryker
SYK
+$35.2M
4
DVAX
Dynavax Technologies
DVAX
+$34.9M
5
UHS icon
Universal Health Services
UHS
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 96.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
51
Elevance Health
ELV
$84.9B
$10.7M 0.5%
24,531
-50,591
-67% -$22.9M
GBIO
52
DELISTED
Generation Bio
GBIO
$9.53M 0.45%
251,444
-8,300
-3% -$393K
ACLX
53
DELISTED
Arcellx
ACLX
$8.62M 0.41%
240,338
-15,494
-6% -$534K
ADAP
54
DELISTED
Adaptimmune Therapeutics
ADAP
$8.13M 0.38%
10,423,135
+2,065,893
+25% +$1.73M
PMVP icon
55
PMV Pharmaceuticals
PMVP
$62.9M
$7.95M 0.37%
1,295,104
+1,066,694
+467% +$7.33M
ERAS icon
56
Erasca
ERAS
$6.34B
$7.74M 0.36%
3,930,633
-866,827
-18% -$2.22M
TSBX
57
DELISTED
Turnstone Biologics
TSBX
$6.01M 0.28%
+1,524,710
New +$13.6M
SGMT icon
58
Sagimet Biosciences
SGMT
$540M
$5.95M 0.28%
+676,453
New +$9.01M
VRDN icon
59
Viridian Therapeutics
VRDN
$2.49B
$5.54M 0.26%
360,830
+67,690
+23% +$1.29M
HOWL icon
60
Werewolf Therapeutics
HOWL
$19.6M
$5.47M 0.26%
2,558,282
+254,391
+11% +$701K
INBX
61
DELISTED
Inhibrx, Inc. Common Stock
INBX
$5.3M 0.25%
288,617
+160,914
+126% +$3.37M
SANA icon
62
Sana Biotechnology
SANA
$949M
$4.81M 0.23%
1,244,139
+1,230,173
+8,808% +$6.61M
SYK icon
63
Stryker
SYK
$129B
$3.31M 0.16%
12,106
-122,916
-91% -$35.2M
XENE icon
64
Xenon Pharmaceuticals
XENE
$6.24B
$2.68M 0.13%
78,587
-21,560
-22% -$806K
CELC icon
65
Celcuity
CELC
$4.55B
$1.92M 0.09%
210,551
-47,162
-18% -$464K
IOBT
66
DELISTED
IO Biotech
IOBT
$1.91M 0.09%
1,353,453
+740,740
+121% +$1.3M
OSCR icon
67
Oscar Health
OSCR
$8B
$1.87M 0.09%
336,166
– –
EDIT icon
68
Editas Medicine
EDIT
$445M
$642K 0.03%
82,281
-358,889
-81% -$3.08M
CMPS
69
Compass Pathways
CMPS
$1.83B
$391K 0.02%
52,871
-122,410
-70% -$1.08M
APLS
70
DELISTED
Apellis Pharmaceuticals
APLS
– –
-274,498
Closed -$25M
AXSM icon
71
CALL
Axsome Therapeutics
AXSM
$10.8B
– –
-200,000
Closed -$14.4M
BSX icon
72
Boston Scientific
BSX
$71.4B
– –
-268,397
Closed -$14.5M
DVAX
73
DELISTED
Dynavax Technologies
DVAX
– –
-2,704,917
Closed -$34.9M
FXI icon
74
CALL
iShares China Large-Cap ETF
FXI
$4.29B
– –
-405,400
Closed -$11M
FXI icon
75
iShares China Large-Cap ETF
FXI
$4.29B
– –
-398,720
Closed -$10.8M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q3 2023 Portfolio in Review

As of Q3 2023, PFM Health Sciences held 91 positions worth $2.12B, down 18% from $2.58B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences withdrew a net $364M in Q3 2023, closing 19 positions and reducing 20 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Lantheus worth $25.9M.

  • PFM Health Sciences's largest Q3 2023 buy was Lantheus: 372,761 shares worth $25.9M.
  • PFM Health Sciences added most to Veeva Systems in Q3 2023, an estimated $16.4M increase.
  • PFM Health Sciences's biggest Q3 2023 reduction was Penumbra, cutting an estimated $46.5M.
  • PFM Health Sciences fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, selling an estimated $112M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $2.12B portfolio in Q3 2023.
  • PFM Health Sciences opened 7 new positions and closed 19 in Q3 2023.
  • PFM Health Sciences's portfolio value fell 18% quarter-over-quarter to $2.12B.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.